Twitter Linkedin-in

Biologics UK: In-Person

21 – 22 March 2022 | London, UK
+ Digital Day: 23 March 2022 | Online
Part of the Biologics Series
Biologics Europe: Online
Virtual Symposium: Oligonucleotides
Biologics UK: In-Person
Biotherapeutics US: Online
Book Now
Biologics UK
21 – 22 March 2022 | London, UK
+ Digital Day: 23 March 2022 | Online

ENGAGE, EDUCATE & ELEVATE

Download Agenda
Register

Europe’s Premier Meeting for Biologics R&D

ENGAGE with peers and selected leading providers in an exciting, successful networking environment

EDUCATE yourself on the latest in research and innovation in our renowned conference programme

ELEVATE your biologics research through immersive, discussion-based sessions within a committed community

Programmes

Proteins & Antibodies

Cutting edge discussions on protein & antibody engineering and development strategies, advancing bispecifics to the clinic & therapeutic use, bioanalysis and vaccine development

Peptides

Comprehensive case studies examining the latest challenges and innovations in early peptide drug development; including peptide synthesis technologies, delivery methods, analytical peptide development and peptide purification strategies

Bispecifics in Discovery & Development

Addressing the latest advances in bispecifics development & platforms, pushing bispecifics to the clinic and therapeutic use.

Key Speakers

The 2022 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the key speakers of Biologics UK: In-Person 2021

Alex McPherson

Alex McPherson

UCB

Seema Kumar EMD Sereno

Seema Kumar

EMD Serono

Stefan Zielonka

Stefan Zielonka

Merck KGaA

Steven McIntyre

Steven McIntyre

Almac Group

William Olson - Regeneron

William Olson

Regeneron

No data was found

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Interactive Sessions

Featuring a series of panel and roundtable discussions pertaining to the latest biologics research and development
Find Out More

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Supported Digitally

Can't attend in-person? Our fully featured online platform runs alongside the event with a dedicated Digital Day to round off the conference after the two days on-site

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
“I liked the mix of presentation topics, and the quality of the talks. The size of the meeting was good, as was the networking time"
Vice President InnovationDuPont
"Topics were of high interest. I liked the opportunity to network and interact with key industry partners. Great presentations - fantastic learning opportunity."
ScientistSanofi
"The event was well organized, with a great line of prominent and knowledgeable speakers.I liked that there was also enough time for networking."
Senior Vice President, Drug DiscoveryTaros
"The talks were a very high quality and had some excellent feedback. The lunch was good and the layout made people interact."
Sales ManagerFortéBio Biologics
"The 8+ hours of networking time allowed optimal time for discussions linked with the pre-organised meetings."
Inside Sales ManagerBio-Techne
Previous
Next
Biologics Post-Event Report
Biologics 2019 Post-Event Report
Statistics, feedback, photos and more from last year's event.
affilogic webinar
Complimentary Webinar
Webinar on 'Nanofitin-Antibody fusion as a novel multispecific platform. Hosted by Mathieu Cinier, Scientific Director, Affilogic.
Thomas Novo Nordisk
Bioconjugation and New Target Discovery
Q&A with Novo Nordisk's Scientific Director, Thomas Hoeg-Jensen
Zealand Webinar
Complimentary Webinar
From Andy Parker, Senior Vice President & Chief Scientific Officer, Zealand Pharma: From Peptide Discovery to Phase 3 – A Zealand Perspective
Tony Evox
Q&A Session with Antonin De Fougerolles
Chief Executive Officer of Evox Therapeutics, Antonin De Fougerolles: The Role of Bispecific Antibodies within the Healthcare Industry
Content Hub Graphic
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.